Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has received notice from the U.S. Food and Drug Administration (FDA) that it has been awarded a new funded cooperative agreement, for $250,000 per year for up to two […]
Cambridge, Mass. and Athens, Greece. Seven Bridges, the leading biomedical data platform and analytics company, and e-NIOS, a biological knowledge discovery start-up, announced a strategic partnership towards data-driven discovery of biomarker signatures. Derivation of robust biomarkers from next generation sequencing and multi-omic data is currently a major bottleneck in precision medicine initiatives. This bottleneck continues to limit […]
Cambridge, Mass. Seven Bridges, the leading biomedical data platform and analytics company, today announced the launch of the new Kids First Data Resource Portal with the Gabriella Miller Kids First Data Resource Center (DRC) at the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia. The Gabriella Miller Kids First Data Resource Center is a new, collaborative, pediatric research […]
Simulations Plus announced today that it received an extension to its funded research collaboration with the FDA to develop the GastroPlus OCAT model. New functionality to mechanistic ocular absorption model in GastroPlus™ supports FDA’s future Innovation Initiative Simulations Plus, Inc. (Nasdaq:SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and […]
Certara’s QSTS division is actively involved in several international partnerships, developing novel modeling and simulation approaches to solve toxicological issues PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced that it has appointed Mark Holbrook, PhD, to the newly-created position of vice president of quantitative […]
Co-sell partnership to provide unparalleled access to Microsoft’s Enterprise customers Eagle Genomics solution enables assessment of viability, efficacy and safety of enterprise branded products Driving digital reinvention of life sciences using artificial intelligence to map the microbiome LONDON, September 2018 - Eagle Genomics joins a specialised group of high-growth startups, earning co-sell status as part […]
We have teamed up with Nebion, to make it easier for users to combine Qlucore Omics Explorer and Genevestigator. This is an excellent combination for investigating RNA-seq gene expression data. Qlucore Omics Explorer and Genevestigator provides users an end-to-end solution for gene expression analyses. The users will benefit from seeing both the details of their […]
Cooperative effort will ensure top quality plants for medical treatment Ness Ziona and Ruhama, Israel – Legalization of cannabis for diverse medical conditions requires top quality control of plant material production. One of the most important quality measurements is the cannabis strain authentication. Cannabis strains differ significantly in the profile of active ingredients, mostly cannabinoids […]
Forges Partnership with Veritas Genetics to Accelerate Creation of Trusted Marketplace for Genomic Data as a Foundation for Data-Driven Medicine SAN FRANCISCO & BOSTON–Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading venture capital firms. The funds will support the company’s mission to usher in the […]
Cambridge, United Kingdom – Congenica, the global provider of clinical genomics interpretation software, today announced the appointment of Mrs Wendy Britten as its new Chief Financial Officer (CFO), effective 1st September, 2018. Mrs Britten will have overall control and responsibility for all financial aspects of the business and will play a key role in business development […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
